Exclusive deal with KSL Biomedical signals PredictImmune’s major move into North America
Cambridge, UK, 22 October: PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today confirmed that it has entered into an exclusive commercial partnership with KSL Biomedical (KSL), to commercialise and provide PredictImmune’s prognostic test for inflammatory bowel disease (IBD), PredictSURE IBD™, throughout North America.
Under the agreement, KSL will commercialise and facilitate the fulfilment…
As well as investing and recruiting 25 graduates and school-leavers at its Cambridge office, Deloitte has also recently welcomed partner, Fran Cousins to the local Cambridge team.
Fran leads the public sector technology and digital risk business within Risk Advisory, working with healthcare, life sciences and medical devices organisations supporting their technology strategy and implementation activities. Prior to joining Deloitte in 2015, Fran worked at Cambridge University Hospitals for 18 years. She was a member of the Board of Directors for 11 years in the roles of Executive Director…
James Veale, product manager at GiroNEX – a spin-out company from Innomech Group – has been named ‘Young Design Engineer of the Year’ at the 10th anniversary British Engineering Excellence Awards ceremony in London on Friday 11 October.
James was chosen as the overall winner within his category in recognition of his technical contribution in helping GiroNEX to develop and launch its first product series at such an early point in his own career, and for his personal qualities as an ambassador for the engineering profession. James joined GiroNEX as a graduate engineer in 2017 and went on to…
Westbury, NY – Oct. 16, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired PPA Research Group, Inc., a human hematologic product provider, based in Gray, TN. This acquisition will significantly expand BioIVT’s immunology and disease-state product portfolios, enhancing its ability to support immuno-oncology and cell therapy researchers.
PPA Research Group operates full-service donor centers in Johnson City, TN and Berkeley, CA focused primarily on producing leukopaks. Leukopaks contain concentrated…
The website for Integrated Biologix (www.ibiologix.com), a fully integrated non-clinical development consultancy for biotherapeutics goes live.
LOUGHBOROUGH, England (October 14, 2019) – Science World, the Fisher Scientific Laboratory Experience, made a successful debut at Leicester Tigers Rugby Club on 10 October. The event, hosted by Thermo Fisher Scientific, showcased the latest in laboratory innovations available through the Fisher Scientific channel. Thousands of products were available for attendees to experience, making it an ideal event for anyone working in or around a laboratory.
Highlights from Science World included the following keynote speakers: Jamie Gallagher who presented “Uncovering the secrets of nanotechnology,”…
AMSBIO announces two new Luciferase assay kits designed to help you improve your gene reporter assays.Gene reporter assays are widely used in research and drug discovery. The development of such cell lines is often time-consuming and costly. Once these cell lines are finally validated, why jeopardize your results with cheap and low-end detection kits that can impact the reproducibility of your experiments in unintended and unanticipated ways. Two reliable and extremely powerful luciferase detection kits - the One-Step Luciferase Assay System and the Dual Luciferase…
Cambridge, UK – 16 October, 2019 – Healx, the AI-powered and patient-inspired technology company specialising in treatments for rare diseases, today announces that it has raised $56 million in a Series B financing round, led by one of Europe’s largest VC firms Atomico and joined by Intel Capital, Global Brain and btov Partners. All previous investors, including Balderton Capital, Amadeus Capital Partners, and Jonathan Milner also participated in the round. The financing will be used to develop the company’s therapeutic pipeline and to launch its global Rare Treatment Accelerator programme.…
Cambridge, UK, 14th October 2019: Mogrify Ltd (Mogrify), a UK company aiming to transform the development of life-saving cell therapies, today announced the initial close of its Series A funding. The Company raised $16 million USD in this round, bringing the total investment to over $20 million USD to date. The funding will support internal cell therapy programs, and the development and out-license of novel IP relating to cell conversions of broad therapeutic interest. Mogrify is also actively recruiting, and will increase headcount to 60 scientific, operational and commercial staff located…
Cambridge UK: 11 October 2019
GlobalData has become the latest Partner to join forces with One Nucleus. The One Nucleus Partner Programme is tailor-made to meet the needs both of the Partner and the interests of One Nucleus members.Saief Kazmi, Account Director commented ‘GlobalData are committed to supporting innovation and advances in healthcare and we are delighted to partner with One Nucleus and the magnificent cluster of talent and scientific acumen. Should members be seeking partners, new clients, funding or looking to better understand existing or new therapy areas our…